Your account is not claimed yet. You can sign up with ORCID to claim your account.

Jesús María Hernández-Rivas (Jesús María Hernández Rivas, Jesús-María Hernández-Rivas, Jesús Maria Hernández-Rivas, Jesús M Hernández-Rivas)

ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Venues

Cancers

American journal of hematology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Torrent Catarineu, Mireia Morgades, Olga García-Calduch, María Paz Queipo de Llano, Pau Montesinos, Irene Navarro, Jesús María Hernández-Rivas, Abelardo Bárez-García, José González-Campos, Itziar Oiartzabal, Marta Valero, Marta Cervera, Teresa Zudaire Ripa, Manuel Albors-Ferreiro, Oriana Lopez-Godino, Cristina Gil-Cortés, Lucía Villalón, Raquel Saldaña, Josep-María Ribera
Results of the compassionate program of inotuzumab ozogamicin for adult patients with relapsed or refractory acute lymphoblastic leukemia in Spain. European journal of haematology (2023)
Sofía Toribio-Castelló, Sandra Castaño-Díez, Ángela Villaverde-Ramiro, Esperanza Such, Montserrat Arnán, Francesc Sole, Marina Díaz-Beyá, Maria Diez Campelo, Mónica Del Rey, Teresa González, Jesús María Hernández-Rivas
Mutational Profile Enables the Identification of a High-Risk Subgroup in Myelodysplastic Syndromes with Isolated Trisomy 8. Cancers 15 (15) (2023)
Elena Vuelta, José L Ordoñez, David J Sanz, Sandra Ballesteros, Jesús María Hernández-Rivas, Lucía Méndez-Sánchez, Manuel A Sanchez-Martin, Ignacio García-Tuñón
CRISPR/Cas9-Directed Gene Trap Constitutes a Selection System for Corrected BCR/ABL Leukemic Cells in CML. International journal of molecular sciences 23 (12) (2022)
Claudia Pérez-Carretero, María Hernández-Sánchez, Teresa González, Miguel Quijada-Álamo, Marta Martín-Izquierdo, Sandra Santos-Mínguez, Cristina Miguel-García, María-Jesús Vidal, Alfonso García-De-Coca, Josefina Galende, Emilia Pardal, Carlos Aguilar, Manuel Vargas-Pabón, Julio Dávila-Valls, Isabel Gascón-Y-Marín, José-Ángel Hernández-Rivas, Rocío Benito, Jesús María Hernández-Rivas, Ana Eugenia Rodríguez Vicente
TRAF3 alterations are frequent in del-3'IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features. American journal of hematology 97 (7) (2022)
Ana Marín-Quilez, Christian Andrea Di Buduo, Lorena Díaz-Ajenjo, Vittorio Abbonante, Elena Vuelta, Paolo Maria M Soprano, Cristina Miguel-García, Sandra Santos-Mínguez, Inmaculada Serramito-Gómez, Pedro Ruiz-Sala, M Jesús Peñarrubia, Emilia Pardal, Jesús María Hernández-Rivas, José Ramón González-Porras, Ignacio García-Tuñón, Rocío Benito, José Rivera, Alessandra Balduini, José Maria Bastida
Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis. Blood (2022)
Mattia D'Agostino, David A Cairns, Juan-José Lahuerta, Ruth Wester, Uta Bertsch, Anders Waage, Elena Zamagni, Maria-Victoria Mateos-Manteca, Daniele Dall'Olio, Niels W C J van de Donk, Graham H Jackson, Serena Rocchi, Hans J Salwender, Joan Bladé Creixenti, Bronno van der Holt, Gastone C Castellani, Francesca Bonello, Andrea Capra, Elias Karl Mai, Jan Dürig, Francesca Gay, Sonja Zweegman, Michele Cavo, Martin F Kaiser, Hartmut Goldschmidt, Jesús María Hernández-Rivas, Alessandra Larocca, Curly T C M Morris, Jesús San F Miguel, Mario Boccadoro, Pieter Sonneveld
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (29) (2022)
Miguel Quijada-Álamo, María Hernández-Sánchez, Ana Eugenia Rodríguez Vicente, Claudia Pérez-Carretero, Alberto Rodríguez-Sánchez, Marta Martín-Izquierdo, Verónica Alonso-Pérez, Ignacio García-Tuñón, José Maria Bastida, María Jesús Vidal-Manceñido, Josefina Galende, Carlos Aguilar, José Antonio Queizán, Isabel González-Gascón Y Marín, José-Ángel Hernández-Rivas, Rocío Benito, José Luis Ordóñez, Jesús María Hernández-Rivas
Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression. Blood cancer journal 11 (7) (2021)
Claudia Pérez-Carretero, Isabel González-Gascón Y Marín, Ana Eugenia Rodríguez Vicente, Miguel Quijada-Álamo, Jose-Ángel Hernández-Rivas, María Hernández-Sánchez, Jesús María Hernández-Rivas
The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment. Diagnostics (Basel, Switzerland) 11 (5) (2021)
Miguel Quijada-Álamo, Claudia Pérez-Carretero, María Hernández-Sánchez, Ana-Eugenia Rodríguez-Vicente, Ana-Belén Herrero, Jesús-María Hernández-Sánchez, Marta Martín-Izquierdo, Sandra Santos-Mínguez, Mónica Del Rey, Teresa González, Araceli Rubio-Martínez, Alfonso García de Coca, Julio Dávila-Valls, José-Ángel Hernández-Rivas, Helen Parker, Jonathan C Strefford, Rocío Benito, José-Luis Ordóñez, Jesús María Hernández-Rivas
Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia. Clinical and translational medicine 11 (2) (2021)

Jesús María Hernández-Rivas.css-eqlu8i{font-size:small;padding-left:4px;} (Jesús María Hernández Rivas, Jesús-María Hernández-Rivas, Jesús Maria Hernández-Rivas, Jesús M Hernández-Rivas)

Publication Activity (10 Years)

Top Topics

Top Venues

Jesús María Hernández-Rivas (Jesús María Hernández Rivas, Jesús-María Hernández-Rivas, Jesús Maria Hernández-Rivas, Jesús M Hernández-Rivas)